Form 8-K - Current report:
SEC Accession No. 0001193125-21-279569
Filing Date
2021-09-22
Accepted
2021-09-22 17:23:31
Documents
13
Period of Report
2021-09-21
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d233524d8k.htm   iXBRL 8-K 24146
2 EX-99.1 d233524dex991.htm EX-99.1 45049
  Complete submission text file 0001193125-21-279569.txt   195032

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA neog-20210921.xsd EX-101.SCH 2885
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE neog-20210921_lab.xml EX-101.LAB 17373
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE neog-20210921_pre.xml EX-101.PRE 10948
6 EXTRACTED XBRL INSTANCE DOCUMENT d233524d8k_htm.xml XML 3326
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-17988 | Film No.: 211270338
SIC: 2835 In Vitro & In Vivo Diagnostic Substances